help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shang, X.-Z.
Right arrow Articles by Chensue, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shang, X.-Z.
Right arrow Articles by Chensue, S. W.
(American Journal of Pathology. 2002;161:257-266.)
© 2002 American Society for Investigative Pathology

Regular Articles

Eosinophil Recruitment in Type-2 Hypersensitivity Pulmonary Granulomas

Source and Contribution of Monocyte Chemotactic Protein-3 (CCL7)

Xiao-Zhou Shang*, Bo-Chin Chiu*, Valerie Stolberg{dagger}, Nicholas W. Lukacs*, Steven L. Kunkel*, Hedwig S. Murphy*{dagger} and Stephen W. Chensue*{dagger}

From the Department of Pathology,*University of Michigan Hospitals, Ann Arbor; and the Departments of Pathology and Laboratory Medicine,{dagger}Veterans Affairs Medical Center, Ann Arbor, Michigan

Monocyte chemotactic protein-3 (MCP-3/CCL7) has potent eosinophil chemoattractant properties. The present study determined its relative contribution to the formation of Th2 cytokine-mediated (type-2) eosinophil-rich interstitial lung granulomas induced by antigens of Schistosoma mansoni eggs. Both MCP-3 transcripts and protein levels were more strongly expressed in lungs with type-2 than with type-1 (mycobacterial antigen-elicited Th1-mediated) granulomas. In vivo treatment with neutralizing antibodies demonstrated that MCP-3 abrogated eosinophil accumulation in type-2 lesions by 40 to 50%. Immunohistochemical staining revealed that MCP-3 localized to vessels in or near granulomas suggesting that endothelial cells were an important in situ source of MCP-3. Maximal MCP-3 transcript expression was abrogated by anti-interleukin-4 treatment. Furthermore, cultured mouse lung endothelial cells displayed augmented MCP-3 production in response to interleukin-4. Together, these results suggest that MCP-3 contributes to a significant component of eosinophil recruitment in the type-2 interstitial granuloma formation and Th2 cytokines promote its production.




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
T. Ishii, T. Fujita, T. Matsushita, K. Yanaba, M. Hasegawa, H. Nakashima, F. Ogawa, K. Shimizu, K. Takehara, T. F. Tedder, et al.
Establishment of Experimental Eosinophilic Vasculitis by IgE-Mediated Cutaneous Reverse Passive Arthus Reaction
Am. J. Pathol., June 1, 2009; 174(6): 2225 - 2233.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. S. Hu, C. M. Freeman, V. R. Stolberg, B. C. Chiu, G. J. Bridger, S. P. Fricker, N. W. Lukacs, and S. W. Chensue
AMD3465, a Novel CXCR4 Receptor Antagonist, Abrogates Schistosomal Antigen-Elicited (Type-2) Pulmonary Granuloma Formation
Am. J. Pathol., August 1, 2006; 169(2): 424 - 432.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. B. Stavitsky
Regulation of Granulomatous Inflammation in Experimental Models of Schistosomiasis
Infect. Immun., January 1, 2004; 72(1): 1 - 12.
[Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. R. Gyetko, S. Sud, and S. W. Chensue
Urokinase-Deficient Mice Fail To Generate a Type 2 Immune Response following Schistosomal Antigen Challenge
Infect. Immun., January 1, 2004; 72(1): 461 - 467.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
B.-C. Chiu, C. M. Freeman, V. R. Stolberg, E. Komuniecki, P. M. Lincoln, S. L. Kunkel, and S. W. Chensue
Cytokine-Chemokine Networks in Experimental Mycobacterial and Schistosomal Pulmonary Granuloma Formation
Am. J. Respir. Cell Mol. Biol., July 1, 2003; 29(1): 106 - 116.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology.